ARS Pharmaceuticals (SPRY) Q2 2026 Earnings

19MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.52
-0.48
-0.45
-0.41

Details

Expected EPS
-0.49
Actual EPS
N/A
Surprise EPS
0.49
Surprise Percent
+100%

Description

ARS Pharmaceuticals (SPRY) will report earnings of for Q2 2026 on May 19, 2026.

0 Comments

Share your thoughts